Trade Summary
On Sep 3, 2026, Hochman David P, See Remarks, Director, purchased $47.9K of Orchestra BioMed Holdings, Inc. (OBIO) across 1 transaction. The filing covers Common Stock, par value $0.0001 per share ("Common Stock") and reflects net buying of $47.9K. Reported prices ranged from $4.79. Insider transactions are sourced from SEC Form 4 disclosures and should be reviewed alongside company fundamentals and the insider's broader trading history.
Company Information
- Company Name
- Orchestra BioMed Holdings, Inc.
- Ticker Symbol
- OBIO
- CIK
- 0001814114
Insider Information
- Name
- Hochman David P
- Role
- See Remarks, Director
- Location
- NEW HOPE, PA
Filing Details
- Filing Date
- Sep 8, 2026
- Transaction Date
- Sep 3, 2026
- Accession Number
- 0001104659-26-105690
- Form Type
- 4
- Net Trading Amount
- $47.9K
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Sep 3, 2026 | Common Stock, par value $0.0001 per share ("Common Stock") | 10,000 | $4.79 | Purchase | $47.9K |
Want live alerts when Hochman David P trades again?
Download Insider Trades to track OBIO, follow insiders, and get mobile alerts when new SEC Form 4 filings are published.
Footnotes
- (F1)The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.73 to $4.79. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.